Additionally, mutations in several genes, such as phosphatidylinositol 3-kinase catalytic alpha (PIK3CA), phosphatase and tensin homolog (PTEN), and Kirsten rat sarcoma viral oncogene homolog (KRAS), play a significant role in NSCLC development (22). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.